← All companies

NERV

Minerva Neurosciences, Inc.

NERV Nasdaq Pharmaceutical Preparations EDGAR ↗

$3.97

-0.05 -1.24%

Key statistics

from XBRL data in SEC filings

Market cap

$185M

Revenue (TTM)

$0.00

Net income (TTM)

-$415M

EPS (TTM)

$-37.03

P/E ratio

—

Dividend yield

—

Free cash flow

-$13.5M

Cash

$32.7M

Total assets

$94.0M

Gross margin

—

52-week range

$1.76 – $12.46

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Modified rights of security holders; Amended charter or bylaws; Shareholder vote results Jun 4, 2026 8-K Entered a material agreement; Other events May 27, 2026 10-Q Quarter ended 2026-03-31 May 5, 2026 8-K Results of operations (earnings release) May 5, 2026 8-K Other events Apr 6, 2026 8-K Director or officer change; Regulation FD disclosure; Other events Apr 2, 2026 10-K Fiscal year ended 2025-12-31 Mar 11, 2026 8-K Results of operations (earnings release) Mar 11, 2026 8-K Regulation FD disclosure; Other events Feb 3, 2026 8-K Director or officer change; Shareholder vote results Dec 22, 2025 8-K Director or officer change; Regulation FD disclosure Nov 19, 2025 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Entered a material agreement; Unregistered sale of equity; Amended charter or bylaws; Regulation FD disclosure Oct 22, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 29, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 21, 2025 8-K Other events Mar 19, 2025 10-K Fiscal year ended 2024-12-31 Feb 25, 2025 8-K Other events Jan 13, 2025 8-K Shareholder vote results Dec 5, 2024 10-Q Quarter ended 2024-09-30 Nov 5, 2024 8-K Delisting notice or listing-rule failure Oct 11, 2024 8-K Other events Sep 16, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Director or officer change May 30, 2024 10-Q Quarter ended 2024-03-31 May 1, 2024 10-K/A Fiscal year ended 2023-12-31 Apr 22, 2024 8-K Delisting notice or listing-rule failure Apr 12, 2024 8-K Other events Feb 27, 2024 10-K/A Fiscal year ended 2023-12-31 Feb 26, 2024 10-K Fiscal year ended 2023-12-31 Feb 22, 2024 10-Q Quarter ended 2023-09-30 Nov 7, 2023 8-K Shareholder vote results Sep 28, 2023 10-Q Quarter ended 2023-06-30 Aug 1, 2023 8-K Entered a material agreement; Unregistered sale of equity; Other events Jun 28, 2023 8-K Other events Jun 20, 2023 8-K Delisting notice or listing-rule failure Jun 2, 2023 10-Q Quarter ended 2023-03-31 May 15, 2023 8-K Director or officer change May 5, 2023